 | • レポートコード：MRC2-11QY12548 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肺がん診断検査のグローバル市場について調査・分析したレポートです。種類別（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他診断方法）市場規模、用途別（精密医療、個別化医療、がんモニタリング）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肺がん診断検査の競争状況、市場シェア ・世界の肺がん診断検査市場：種類別市場規模 2015年-2020年（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他診断方法） ・世界の肺がん診断検査市場：種類別市場規模予測 2021年-2026年（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他診断方法） ・世界の肺がん診断検査市場：用途別市場規模 2015年-2020年（精密医療、個別化医療、がんモニタリング） ・世界の肺がん診断検査市場：用途別市場規模予測 2021年-2026年（精密医療、個別化医療、がんモニタリング） ・北米の肺がん診断検査市場分析：米国、カナダ ・ヨーロッパの肺がん診断検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肺がん診断検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肺がん診断検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肺がん診断検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Advpharma Inc、AIT Austrian Institute of Technology GmbH、Courtagen Life Sciences Inc、DiagnoCure Inc. (Inactive)、BioMark Diagnostics Inc.、BioMarker Strategies LLC、Emory University、Epigenomics AG、GlycoZym、HalioDx SAS、Louisville Bioscience, Inc.、Mayo Clinic US ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Lung Cancer Diagnostic Tests Market
The global Lung Cancer Diagnostic Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Lung Cancer Diagnostic Tests Scope and Market Size
Lung Cancer Diagnostic Tests market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Diagnostic Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
HalioDx SAS
Louisville Bioscience, Inc.
Mayo Clinic US
Market segment by Type, the product can be split into
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
Market segment by Application, split into
Precision Medicine
Personalized Medicine
Cancer Monitoring
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lung Cancer Diagnostic Tests Revenue
1.4 Market by Type
1.4.1 Global Lung Cancer Diagnostic Tests Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunoassays
1.4.3 Flow Cytometry
1.4.4 Rapid Tests
1.4.5 Molecular Assays
1.4.6 Tissue Arrays
1.4.7 Circulating Tumor Cells
1.4.8 Pharmacodiagnostics
1.4.9 Biomarkers
1.4.10 Other Diagnostics Methods
1.5 Market by Application
1.5.1 Global Lung Cancer Diagnostic Tests Market Share by Application: 2020 VS 2026
1.5.2 Precision Medicine
1.5.3 Personalized Medicine
1.5.4 Cancer Monitoring
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Diagnostic Tests Market Perspective (2015-2026)
2.2 Global Lung Cancer Diagnostic Tests Growth Trends by Regions
2.2.1 Lung Cancer Diagnostic Tests Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lung Cancer Diagnostic Tests Historic Market Share by Regions (2015-2020)
2.2.3 Lung Cancer Diagnostic Tests Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lung Cancer Diagnostic Tests Market Growth Strategy
2.3.6 Primary Interviews with Key Lung Cancer Diagnostic Tests Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Diagnostic Tests Players by Market Size
3.1.1 Global Top Lung Cancer Diagnostic Tests Players by Revenue (2015-2020)
3.1.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Players (2015-2020)
3.1.3 Global Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lung Cancer Diagnostic Tests Market Concentration Ratio
3.2.1 Global Lung Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostic Tests Revenue in 2019
3.3 Lung Cancer Diagnostic Tests Key Players Head office and Area Served
3.4 Key Players Lung Cancer Diagnostic Tests Product Solution and Service
3.5 Date of Enter into Lung Cancer Diagnostic Tests Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Lung Cancer Diagnostic Tests Historic Market Size by Type (2015-2020)
4.2 Global Lung Cancer Diagnostic Tests Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)
5.2 Global Lung Cancer Diagnostic Tests Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lung Cancer Diagnostic Tests Market Size (2015-2020)
6.2 Lung Cancer Diagnostic Tests Key Players in North America (2019-2020)
6.3 North America Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
6.4 North America Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)
7 Europe
7.1 Europe Lung Cancer Diagnostic Tests Market Size (2015-2020)
7.2 Lung Cancer Diagnostic Tests Key Players in Europe (2019-2020)
7.3 Europe Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
7.4 Europe Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)
8 China
8.1 China Lung Cancer Diagnostic Tests Market Size (2015-2020)
8.2 Lung Cancer Diagnostic Tests Key Players in China (2019-2020)
8.3 China Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
8.4 China Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)
9 Japan
9.1 Japan Lung Cancer Diagnostic Tests Market Size (2015-2020)
9.2 Lung Cancer Diagnostic Tests Key Players in Japan (2019-2020)
9.3 Japan Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
9.4 Japan Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Lung Cancer Diagnostic Tests Market Size (2015-2020)
10.2 Lung Cancer Diagnostic Tests Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
10.4 Southeast Asia Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)
11 India
11.1 India Lung Cancer Diagnostic Tests Market Size (2015-2020)
11.2 Lung Cancer Diagnostic Tests Key Players in India (2019-2020)
11.3 India Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
11.4 India Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Lung Cancer Diagnostic Tests Market Size (2015-2020)
12.2 Lung Cancer Diagnostic Tests Key Players in Central & South America (2019-2020)
12.3 Central & South America Lung Cancer Diagnostic Tests Market Size by Type (2015-2020)
12.4 Central & South America Lung Cancer Diagnostic Tests Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Advpharma Inc
13.1.1 Advpharma Inc Company Details
13.1.2 Advpharma Inc Business Overview
13.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Introduction
13.1.4 Advpharma Inc Revenue in Lung Cancer Diagnostic Tests Business (2015-2020))
13.1.5 Advpharma Inc Recent Development
13.2 AIT Austrian Institute of Technology GmbH
13.2.1 AIT Austrian Institute of Technology GmbH Company Details
13.2.2 AIT Austrian Institute of Technology GmbH Business Overview
13.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Introduction
13.2.4 AIT Austrian Institute of Technology GmbH Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
13.2.5 AIT Austrian Institute of Technology GmbH Recent Development
13.3 Courtagen Life Sciences Inc
13.3.1 Courtagen Life Sciences Inc Company Details
13.3.2 Courtagen Life Sciences Inc Business Overview
13.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Introduction
13.3.4 Courtagen Life Sciences Inc Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
13.3.5 Courtagen Life Sciences Inc Recent Development
13.4 DiagnoCure Inc. (Inactive)
13.4.1 DiagnoCure Inc. (Inactive) Company Details
13.4.2 DiagnoCure Inc. (Inactive) Business Overview
13.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Introduction
13.4.4 DiagnoCure Inc. (Inactive) Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
13.4.5 DiagnoCure Inc. (Inactive) Recent Development
13.5 BioMark Diagnostics Inc.
13.5.1 BioMark Diagnostics Inc. Company Details
13.5.2 BioMark Diagnostics Inc. Business Overview
13.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Introduction
13.5.4 BioMark Diagnostics Inc. Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
13.5.5 BioMark Diagnostics Inc. Recent Development
13.6 BioMarker Strategies LLC
13.6.1 BioMarker Strategies LLC Company Details
13.6.2 BioMarker Strategies LLC Business Overview
13.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Introduction
13.6.4 BioMarker Strategies LLC Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
13.6.5 BioMarker Strategies LLC Recent Development
13.7 Emory University
13.7.1 Emory University Company Details
13.7.2 Emory University Business Overview
13.7.3 Emory University Lung Cancer Diagnostic Tests Introduction
13.7.4 Emory University Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
13.7.5 Emory University Recent Development
13.8 Epigenomics AG
13.8.1 Epigenomics AG Company Details
13.8.2 Epigenomics AG Business Overview
13.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Introduction
13.8.4 Epigenomics AG Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
13.8.5 Epigenomics AG Recent Development
13.9 GlycoZym
13.9.1 GlycoZym Company Details
13.9.2 GlycoZym Business Overview
13.9.3 GlycoZym Lung Cancer Diagnostic Tests Introduction
13.9.4 GlycoZym Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
13.9.5 GlycoZym Recent Development
13.10 HalioDx SAS
13.10.1 HalioDx SAS Company Details
13.10.2 HalioDx SAS Business Overview
13.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Introduction
13.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
13.10.5 HalioDx SAS Recent Development
13.11 Louisville Bioscience, Inc.
10.11.1 Louisville Bioscience, Inc. Company Details
10.11.2 Louisville Bioscience, Inc. Business Overview
10.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Introduction
10.11.4 Louisville Bioscience, Inc. Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
10.11.5 Louisville Bioscience, Inc. Recent Development
13.12 Mayo Clinic US
10.12.1 Mayo Clinic US Company Details
10.12.2 Mayo Clinic US Business Overview
10.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Introduction
10.12.4 Mayo Clinic US Revenue in Lung Cancer Diagnostic Tests Business (2015-2020)
10.12.5 Mayo Clinic US Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Lung Cancer Diagnostic Tests Key Market Segments
Table 2. Key Players Covered: Ranking by Lung Cancer Diagnostic Tests Revenue
Table 3. Ranking of Global Top Lung Cancer Diagnostic Tests Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lung Cancer Diagnostic Tests Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunoassays
Table 6. Key Players of Flow Cytometry
Table 7. Key Players of Rapid Tests
Table 8. Key Players of Molecular Assays
Table 9. Key Players of Tissue Arrays
Table 10. Key Players of Circulating Tumor Cells
Table 11. Key Players of Pharmacodiagnostics
Table 12. Key Players of Biomarkers
Table 13. Key Players of Other Diagnostics Methods
Table 14. Global Lung Cancer Diagnostic Tests Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Lung Cancer Diagnostic Tests Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Lung Cancer Diagnostic Tests Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Lung Cancer Diagnostic Tests Market Share by Regions (2015-2020)
Table 18. Global Lung Cancer Diagnostic Tests Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Lung Cancer Diagnostic Tests Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Lung Cancer Diagnostic Tests Market Growth Strategy
Table 24. Main Points Interviewed from Key Lung Cancer Diagnostic Tests Players
Table 25. Global Lung Cancer Diagnostic Tests Revenue by Players (2015-2020) (Million US$)
Table 26. Global Lung Cancer Diagnostic Tests Market Share by Players (2015-2020)
Table 27. Global Top Lung Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Diagnostic Tests as of 2019)
Table 28. Global Lung Cancer Diagnostic Tests by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Lung Cancer Diagnostic Tests Product Solution and Service
Table 31. Date of Enter into Lung Cancer Diagnostic Tests Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Lung Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 34. Global Lung Cancer Diagnostic Tests Market Size Share by Type (2015-2020)
Table 35. Global Lung Cancer Diagnostic Tests Revenue Market Share by Type (2021-2026)
Table 36. Global Lung Cancer Diagnostic Tests Market Size Share by Application (2015-2020)
Table 37. Global Lung Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 38. Global Lung Cancer Diagnostic Tests Market Size Share by Application (2021-2026)
Table 39. North America Key Players Lung Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Lung Cancer Diagnostic Tests Market Share (2019-2020)
Table 41. North America Lung Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 42. North America Lung Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 43. North America Lung Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 44. North America Lung Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 45. Europe Key Players Lung Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Lung Cancer Diagnostic Tests Market Share (2019-2020)
Table 47. Europe Lung Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Lung Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 49. Europe Lung Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Lung Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 51. China Key Players Lung Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 52. China Key Players Lung Cancer Diagnostic Tests Market Share (2019-2020)
Table 53. China Lung Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 54. China Lung Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 55. China Lung Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 56. China Lung Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 57. Japan Key Players Lung Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Lung Cancer Diagnostic Tests Market Share (2019-2020)
Table 59. Japan Lung Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Lung Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 61. Japan Lung Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Lung Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Lung Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Lung Cancer Diagnostic Tests Market Share (2019-2020)
Table 65. Southeast Asia Lung Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Lung Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 67. Southeast Asia Lung Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Lung Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 69. India Key Players Lung Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 70. India Key Players Lung Cancer Diagnostic Tests Market Share (2019-2020)
Table 71. India Lung Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 72. India Lung Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 73. India Lung Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 74. India Lung Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Lung Cancer Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Lung Cancer Diagnostic Tests Market Share (2019-2020)
Table 77. Central & South America Lung Cancer Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Lung Cancer Diagnostic Tests Market Share by Type (2015-2020)
Table 79. Central & South America Lung Cancer Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Lung Cancer Diagnostic Tests Market Share by Application (2015-2020)
Table 81. Advpharma Inc Company Details
Table 82. Advpharma Inc Business Overview
Table 83. Advpharma Inc Product
Table 84. Advpharma Inc Revenue in Lung Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 85. Advpharma Inc Recent Development
Table 86. AIT Austrian Institute of Technology GmbH Company Details
Table 87. AIT Austrian Institute of Technology GmbH Business Overview
Table 88. AIT Austrian Institute of Technology GmbH Product
Table 89. AIT Austrian Institute of Technology GmbH Revenue in Lung Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 90. AIT Austrian Institute of Technology GmbH Recent Development
Table 91. Courtagen Life Sciences Inc Company Details
Table 92. Courtagen Life Sciences Inc Business Overview
Table 93. Courtagen Life Sciences Inc Product
Table 94. Courtagen Life Sciences Inc Revenue in Lung Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 95. Courtagen Life Sciences Inc Recent Development
Table 96. DiagnoCure Inc. (Inactive) Company Details
Table 97. DiagnoCure Inc. (Inactive) Business Overview
Table 98. DiagnoCure Inc. (Inactive) Product
Table 99. DiagnoCure Inc. (Inactive) Revenue in Lung Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 100. DiagnoCure Inc. (Inactive) Recent Development
Table 101. BioMark Diagnostics Inc. Company Details
Table 102. BioMark Diagnostics Inc. Business Overview
Table 103. BioMark Diagnostics Inc. Product
Table 104. BioMark Diagnostics Inc. Revenue in Lung Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 105. BioMark Diagnostics Inc. Recent Development
Table 106. BioMarker Strategies LLC Company Details
Table 107. BioMarker Strategies LLC Business Overview
Table 108. BioMarker Strategies LLC Product
Table 109. BioMarker Strategies LLC Revenue in Lung Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 110. BioMarker Strategies LLC Recent Development
Table 111. Emory University Company Details
Table 112. Emory University Business Overview
Table 113. Emory University Product
Table 114. Emory University Revenue in Lung Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 115. Emory University Recent Development
Table 116. Epigenomics AG Business Overview
Table 117. Epigenomics AG Product
Table 118. Epigenomics AG Company Details
Table 119. Epigenomics AG Revenue in Lung Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 120. Epigenomics AG Recent Development
Table 121. GlycoZym Company Details
Table 122. GlycoZym Business Overview
Table 123. GlycoZym Product
Table 124. GlycoZym Revenue in Lung Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 125. GlycoZym Recent Development
Table 126. HalioDx SAS Company Details
Table 127. HalioDx SAS Business Overview
Table 128. HalioDx SAS Product
Table 129. HalioDx SAS Revenue in Lung Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 130. HalioDx SAS Recent Development
Table 131. Louisville Bioscience, Inc. Company Details
Table 132. Louisville Bioscience, Inc. Business Overview
Table 133. Louisville Bioscience, Inc. Product
Table 134. Louisville Bioscience, Inc. Revenue in Lung Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 135. Louisville Bioscience, Inc. Recent Development
Table 136. Mayo Clinic US Company Details
Table 137. Mayo Clinic US Business Overview
Table 138. Mayo Clinic US Product
Table 139. Mayo Clinic US Revenue in Lung Cancer Diagnostic Tests Business (2015-2020) (Million US$)
Table 140. Mayo Clinic US Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Diagnostic Tests Market Share by Type: 2020 VS 2026
Figure 2. Immunoassays Features
Figure 3. Flow Cytometry Features
Figure 4. Rapid Tests Features
Figure 5. Molecular Assays Features
Figure 6. Tissue Arrays Features
Figure 7. Circulating Tumor Cells Features
Figure 8. Pharmacodiagnostics Features
Figure 9. Biomarkers Features
Figure 10. Other Diagnostics Methods Features
Figure 11. Global Lung Cancer Diagnostic Tests Market Share by Application: 2020 VS 2026
Figure 12. Precision Medicine Case Studies
Figure 13. Personalized Medicine Case Studies
Figure 14. Cancer Monitoring Case Studies
Figure 15. Lung Cancer Diagnostic Tests Report Years Considered
Figure 16. Global Lung Cancer Diagnostic Tests Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Lung Cancer Diagnostic Tests Market Share by Regions: 2020 VS 2026
Figure 18. Global Lung Cancer Diagnostic Tests Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Lung Cancer Diagnostic Tests Market Share by Players in 2019
Figure 21. Global Top Lung Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Diagnostic Tests as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Lung Cancer Diagnostic Tests Revenue in 2019
Figure 23. North America Lung Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Lung Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Lung Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Lung Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Lung Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Lung Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Lung Cancer Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Bottom-up and Top-down Approaches for This Report
Figure 31. Data Triangulation
Figure 32. Key Executives Interviewed
肺がん診断の世界市場（～2026年） Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring. As people's awareness of cancer increases and techno…- 循環腫瘍細胞（CTC）＆がん幹細胞の世界市場（～2026年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 肺がんリキッドバイオプシーの世界市場（～2026年） Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time. Market Analysis and Insigh…
- 肺癌の世界市場（～2026年） Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as prim…
- 乳癌スクリーニング検査の世界市場（～2026年） Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the sig…